ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

721
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
bullish•Celltrion Inc
•07 Aug 2026 14:08

Primer: Celltrion Inc (068270 KS) - Aug 2026

Celltrion is poised for accelerated growth, driven by the strong market penetration of new, high-margin biosimilar products and the strategic...

Logo
105 Views
Share
bullish•Celltrion
•17 Nov 2025 16:03

Primer: Celltrion (068270 KP) - Nov 2025

Celltrion is strategically transitioning from a biosimilar powerhouse to a global innovative biopharmaceutical company, underscored by the...

Logo
207 Views
Share
x